Webinar Date/Time: Tue, Nov 19, 2024 11:00 AM EST
Author - David Miller
Addressing Supply Chain Challenges & Improving Patient...
Scott Brunner, CEO, and Tenille Davis, Chief Advocacy Officer, of the Alliance for Pharmacy...
Discovery to Commercialization: The Right Partnerships are Key...
In this rapidly changing environment, your choice of CDMO partner is critical. The right...
Homeopathic Industry Group Wants Court to Exclude It From...
By John W.M. Claud & Deborah L. Livornese & Charles D. Snow — On October 21, 2024, the Alliance...
Tech Transfer in the New World of New Modalities
Emerging therapies, patient-centric medicines, and the ever-changing world of bio/pharmaceuticals...
A Reversal on Sequencing? Proposed Legislation Would Allow...
By Gail H. Javitt & Jeffrey N. Gibbs — A recent blog post focused on the potentially negative...
Novartis and Monte Rosa Therapeutics Form $2.1 Billion Global...
The collaboration aims to advance clinical development of a Phase I drug candidate, MRT-6160, and...
AAPS PharmSci 360 2024: Big Data and Variation in Excipient...
Pauline Janssen of DFE Pharma gave a presentation on the utility of analyzing big data sets to...
FDA Guidance Outlines a Framework for the Evaluation of...
By Mark A. Tobolowsky — The neonatal period is a unique and complex period of rapid growth and...
WHO Activates Global Health Emergency Corp in Response to Mpox
WHO and its partners are providing support to countries dealing with mpox outbreaks.